Stein-Gold, L., Elewski, B., Draelos, Z., & Lin, T. (2020). Safety and Efficacy of a Fixed Combination Halobetasol Propionate 0.01%/Tazarotene 0.045% (HP/TAZ) Lotion in the Treatment of Females With Moderate-to-Severe Plaque Psoriasis. SKIN The Journal of Cutaneous Medicine, 4(1), S9. Retrieved from https://jofskin.org/33014/index.php/skin/article/view/822